Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected.

By D. Marvel, D. Gabrilovich. Journal of Clinical Investigation, 2015

962 citations recorded by the source corpus.

Subfields: Immunology

View Paper: https://www.semanticscholar.org/paper/b158eb8f68232ab84acba8cffb21c92020808ca0

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

1. D. Gabrilovich
2. T. Condamine
3. Je-in Youn
4. E. Tcyganov
5. Yiping Yang
6. Vinit Kumar
7. Sima Patel
8. S. Albelda

Citations in the corpus

• Cancer immunotherapy: harnessing the immune system to battle cancer. (2015, background): “Marvel and Gabrilovich review recent developments in the role of MDSCs in cancer (6).”
• The nature of myeloid-derived suppressor cells in the tumor microenvironment (2016, background): “The morphologic and phenotypic characteristics of both murine and human MDSC have been described in several recent reviews [2–4] and will not be discussed here.”
• Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients (2016, result): “This directly supports the notion that PMN-MDSCs represent a distinct functional state of pathological activation of neutrophils in cancer (30, 31) and is consistent with the analysis of gene expression performed in mice, which demonstrated differences in transcriptome between granulocytes isolated ”